Department of General, Visceral and Transplant Surgery, Medical University of Graz, Graz, Austria.
Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Front Immunol. 2020 Feb 27;11:192. doi: 10.3389/fimmu.2020.00192. eCollection 2020.
Due to higher vulnerability and immunogenicity of extended criteria donor (ECD) organs used for organ transplantation (Tx), the discovery of new treatment strategies, involving tissue allorecognition pathways, is important. The implementation of machine perfusion (MP) led to improved estimation of the organ quality and introduced the possibility to achieve graft reconditioning prior to Tx. A significant number of experimental and clinical trials demonstrated increasing support for MP as a promising method of ECD organ preservation compared to classical static cold storage. MP reduced ischemia-reperfusion injury resulting in the protection from inadequate activation of innate immunity. However, there are no general agreements on MP protocols, and clinical application is limited. The objective of this comprehensive review is to summarize literature on immunological effects of MP of ECD organs based on experimental studies and clinical trials.
由于用于器官移植 (Tx) 的扩展标准供体 (ECD) 器官具有更高的脆弱性和免疫原性,因此发现涉及组织同种异体识别途径的新治疗策略非常重要。机器灌注 (MP) 的实施改善了对器官质量的评估,并引入了在 Tx 之前实现移植物再调理的可能性。大量的实验和临床试验表明,与传统的静态冷藏相比,MP 作为 ECD 器官保存的一种有前途的方法得到了越来越多的支持。MP 减少了缺血再灌注损伤,从而防止了固有免疫的过度激活。然而,目前还没有关于 MP 方案的普遍共识,临床应用也受到限制。本综述的目的是总结基于实验研究和临床试验的 ECD 器官 MP 的免疫学效应的文献。